Generation of the induced pluripotent stem cell line LEIi023-A from a rod-cone dystrophy patient carrying the dominant PRPF31 c.267del variant
Stem Cell Research · 2025
DOI: 10.1016/j.scr.2025.103705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Research, 2025. Verfasst von Dan Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Eye Proteins, Cone-Rod Dystrophies. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council, Government of Western Australia Future Health Research and Innovation Fund, McCusker Charitable Foundation.
Abstract (Originalsprache)
The human induced pluripotent stem cell line LEIi023-A was generated from a 51-year-old female patient with retinitis pigmentosa 11 (RP11) caused by a single nucleotide deletion in the PRPF31 gene, (NM 015629.3: c.267del, p.(Glu89Aspfs*11)). Reprogramming the patient dermal fibroblasts was performed using episomal plasmids expressing reprogramming factors: OCT4, SOX2, KLF4, LMYC, LIN28, p53 shRNA and miR-302/367. LEIi023-A displayed expression of pluripotent stem cell markers, a normal karyotype and capability for differentiation of the three germ layers and retinal pigment epithelial cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia.
- Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.
- Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
- Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia; Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Phy…
- Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia; Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia; A…
- Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia; Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia. E…
Förderung
- National Health and Medical Research Council
- Government of Western Australia Future Health Research and Innovation Fund
- McCusker Charitable Foundation
- Retina Australia Queensland Inc
- Department of Health, Government of Western Australia
Zitieren
APA
Zhang, D., Huang, D., Chen, S. C., Roshandel, D., Lamey, T. M., Thompson, J. A., McLaren, T. L., Chen, F. K., & McLenachan, S. (2025). Generation of the induced pluripotent stem cell line LEIi023-A from a rod-cone dystrophy patient carrying the dominant PRPF31 c.267del variant. Stem Cell Research. https://doi.org/10.1016/j.scr.2025.103705
Vancouver
Zhang D, Huang D, Chen SC, Roshandel D, Lamey TM, Thompson JA, et al. Generation of the induced pluripotent stem cell line LEIi023-A from a rod-cone dystrophy patient carrying the dominant PRPF31 c.267del variant. Stem Cell Research. 2025. doi:10.1016/j.scr.2025.103705
BibTeX
@article{Zhang2025,
author = {Zhang, Dan and Huang, Di and Chen, Shang-Chih and Roshandel, Danial and Lamey, Tina M and Thompson, Jennifer A and McLaren, Terri L and Chen, Fred K and McLenachan, Samuel},
title = {Generation of the induced pluripotent stem cell line LEIi023-A from a rod-cone dystrophy patient carrying the dominant PRPF31 c.267del variant},
journal = {Stem Cell Research},
year = {2025},
doi = {10.1016/j.scr.2025.103705}
}
EUVIMED